Emerging fields for therapeutic targeting of the aldosterone-mineralocorticoid receptor signaling pathway
- PMID: 35174485
- DOI: 10.1111/bph.15808
Emerging fields for therapeutic targeting of the aldosterone-mineralocorticoid receptor signaling pathway
References
REFERENCES
-
- Alexander, S. P., Cidlowski, J. A., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Southan, C., Davies, J. A., Coons, L., Fuller, P. J., Korach, K. S., & Young, M. J. (2021). THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Nuclear hormone receptors. British Journal of Pharmacology, 178(S1), S246-S263. https://doi.org/10.1111/bph.15540
-
- Alexander, S. P., Mathie, A., Peters, J. A., Veale, E. L., Striessnig, J., Kelly, E., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Southan, C., Davies, J. A., Aldrich, R. W., Attali, B., Baggetta, A. M., Becirovic, E., Biel, M., Bill, R. M., Catterall, W. A., … Zhu, M. (2021). THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Ion channels. British Journal of Pharmacology, 178(S1), S157-S245. https://doi.org/10.1111/bph.15539
-
- Bakris, G. L., Agarwal, R., Anker, S. D., Pitt, B., Ruilope, L. M., Rossing, P., Kolkhof, P., Nowack, C., Schloemer, P., Joseph, A., Filippatos, G., & FIDELIO-DKD Investigators. (2020). Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. The New England Journal of Medicine, 383(23), 2219-2229. https://doi.org/10.1056/NEJMoa2025845
-
- Barrera-Chimal, J., Jaisser, F., & Anders, H. J. (2022). The mineralocorticoid receptor in chronic kidney disease. British Journal of Pharmacology, 179(13), 3152-3164. https://doi.org/10.1111/bph.15734
-
- Bauersachs, J., & Lopez-Andres, N. (2022). Mineralocorticoid receptor in cardiovascular diseases-clinical trials and mechanistic insights. British Journal of Pharmacology, 179(13), 3119-3134. https://doi.org/10.1111/bph.15708
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources